Save the Date!

CVRI Burton E. Sobel Visiting Professor: Valentin Fuster, MD, PhD

February 13-15, 2019

Valentin Fuster, MD, PhD, serves as The Mount Sinai Medical Hospital as Physician-in-Chief, as well as, Director of Mount Sinai Heart Center.  Dr. Fuster is the General Director of the National Center for Cardiovascular Investigation or CNIC (equivalent to NHLBI) in Madrid, Spain.  Dr. Fuster has held innumerable positions including those of President of the American Heart Association, President of the World Heart Federation, member of the US National Academy of Medicine, member of the European Horizon 2020 Scientific Panel of Health, Council member of the US National Heart, Lung and Blood Institute, and President of the Training Program of the American College of Cardiology.

Dr. Fuster is an author on more than 1,000 scientific articles.  He was named Editor-in-Chief of the journal Nature Reviews in Cardiology and recently Editor-in-Chief of the Journal of the American College of Cardiology.  His research into the origin of cardiovascular events has contributed to improved treatment of heart attack patients.

His events include a Career Development in Academic Medicine Q&A, Case Presentations by Cardiology Fellows on Acute Coronary Syndromes, and a Medicine Grand Rounds program titled "The Evolving Science of Health: Imaging, Genetics and Behavior".  *These events are made possible by a generous gift from Martin Bloomfield, MD '60 to the CVRI.

In advance of Dr. Fuster's visit, CVRI's Early Career Advisory Committee is co-sponsoring a journal club in review of Dr. Fuster's work on patients with diabetes undergoing coronary revascularization.  The article can be found here.

NEW Funding Opportunity for Early Career Investigators in Cardiovascular Research

The complete application is due by February 15, 2019.

The Early Career Advisory Committee of the CVRI is pleased to announce a unique funding opportunity for Early Career investigators who are developing new skills and/or who are seeking a novel research experience aimed at developing a career in cardiovascular research.


  • Early career investigators at UVM who are working with a UVM mentor or an external (non-UVM) mentor
  • Early career investigators at external institutions who will be working with a mentor at UVM
  • For the purpose of this funding, early career investigators are considered to be:
    • Undergraduate, Masters, and PhD students
    • 2nd, 3rd, and 4th year medical students
    • Postdoctoral fellows
    • Residents and clinical fellows
    • Faculty and Staff within 5 years of their first appointment

Funding: Applications requesting up to $10,000 will be considered.

For more details and application instructions, please contact

Twitter in Medical Research Session

CVRI's Early Career Advisory Committee hosted a hands-on Twitter Session with UVM Larner College of Medicine and UVM Medical Center's social media experts featuring a "how-to Twitter" start up tutorial, building research and clinical networks, and how to be part of the growing Twitter science community!

CVRI's Mary Cushman, MD also presented on how she utilizes Twitter to create network connections and utilize Twitter to facilitate meaningful science.

The event concluded with a spontaneous "Drop and Give Me 20" fitness shout out for science!

Mark Ray Rides (again) for Heart Health

For the past 17 years, Mark Ray, a member of CVRI's Cardiovascular Leadership Council, and his cycling and fundraising partner Steve Gronlund, have devoted countless hours of training and cycling to honor the memory of Mark's father--who died of heart disease at age 64-- and raise funds for heart disease research and prevention.

For this year's 18th annual Jim Ray Memorial Heart Ride, Mark (on the left) and Steve (center) were joined by Steve's boyhood friend Dan Nelson, who had heart surgery the previous October to repair a mitral valve.  The trio started at 4:45 a.m. in Saint-Jérôme, Quebec, just north of Montreal, and covered 200 miles (also known as a "double century") on a rails-to-trails route called Le P'tit Train du Nord through the Laurentian Mountains. Seventeen hours later (13 of them spent pedaling!) they returned to Saint-Jérôme.  Read more about their adventure here.

As in recent years, the funds raised from this ride will support CVRI programs.  If you'd like to make a donation and push this year's effort even further past the team's goal, please click here.

Developing a Career in Cardiovascular Science

CVRI's Early Career Advisory Committee sponsored a panel discussion by Larner College of Medicine alumni, who shared their career experiences with UVM's cardiovascular research community, trainees and students, and alumni visitors.  The panelists provided insights on how to develop a scientific career and, because of their diverse career paths, attendees heard different perspectives on collaborations, networking, and grantsmanship.  A networking reception followed the panel discussion.

Sincere thanks to our panelists:

Edward Havranek, MD '83, Professor, Division of Cardiology, University of Colorado School of Medicine and Director of Medicine, Denver Health.

Albert Sinusas, MD '83, Professor of Medicine (Cardiovascular Medicine) and Radiology and Biomedical Imaging, Yale University School of Medicine; Director, Yale Translational Research Imaging Center; Director, Advanced Cardiovascular Imaging, Yale New Haven Hospital.

David Warshaw, PhD '79, Professor and Chair, Department of Molecular Physiology and Biophysics, UVM Larner College of Medicine.

Marilyn Cipolla, PhD '97, Professor, Department of Neurological Sciences with joint appointments in the Departments of Obstetrics, Gynecology & Reproductive Sciences and Pharmacology, UVM Larner College of Medicine.

Mark Your Calendars

January 22: CVRI's Early Career Advisory Committee will be hosting a Research Symposium from 5:00-7:00 pm in the Davis Auditorium, UVM MC.  An evening reception with food, drink and conversation highlighting the work of early career junior investigators.

February 13-15: Burton E. Sobel Visiting Professor Valentin Fuster, MD, PhD, Mt. Sinai Heart

February 15: Application Deadline for the ECAC Clinical, Translational & Basic Science Research Award

February 19: Join us at Community Medical School featuring "heart talk" entitled "Bigger Isn't Better: Risks & Reasons for an Enlarged Heart" by Jonathan Flyer, MD & David Warshaw, MD

March 7-8: Visiting Professor Geoffrey Pitt, MD, Weill Cornell

News and Announcements

Have a cardiovascular speaker you'd like to bring to campus?

Information on CVRI Co-Sponsorship of Cardiovascular Seminars can be found on the Application for Visiting Professor Funding

CVRI provides internal review of grant applications to support cardiovascular research. E-mail CVRI for more information.  *NOTE: The request for internal review must be made at least 6 weeks before the submission deadline.

CVRI Travel Awards

CVRI travel awards are available to support trainees and junior investigators presenting abstracts at regional and national scientific meetings.  These competitive awards are for reimbursement of presentation-related expenses of up to $2,000; more details can be found on the application for funding.

CVRI Annual Report

AR for 2017_Cover View the Flipbook >>



Editor-In-Chief for New Journal

The International Society on Thrombosis and Haemostasis (ISTH) recently announced the launch of its new open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH), naming Mary Cushman, MD, MSc, as its inaugural Editor-In-Chief. Dr. Cushman, a member of the CVRI Board of Directors, is professor of medicine in the Hematology/Oncology Division of the UVM Department of Medicine and Director of the Thrombosis and Hemostasis Program at The UVM Medical Center.

RTPH will publish a broad array of article types covering the widest possible spectrum of topics in thrombosis, hemostasis, and related areas, including studies by multidisciplinary research groups from emerging areas of research and under-represented regions of the world as well as studies and trials covering quality of care, outcomes, and dissemination and implementation science.

Click here to visit the RPTH homepage.

Pioneering Heart Failure Discovery

More than 15 years ago, David Warshaw, PhD, and coworkers discovered the precise malfunction of a specific protein in the heart that leads to hypertrophic cardiomyopathy (HCM). An inherited disease, HCM can cause the heart to thicken and stop pumping blood effectively, leading to heart failure.  Now, a team of scientists has used some of Warshaw’s earlier findings to develop a possible therapy to prevent HCM. Warshaw, professor and chair of molecular physiology and biophysics at UVM and a Director of CVRI, wrote about the significance of this potential therapy for a “Perspectives” column in the February 5, 2016 issue of the journal Science. This may offer a generalized approach to solving hypertrophic cardiomyopathy,” says Warshaw. I think it’s extremely promising."

Read Dr. Warshaw’s column and the report.